Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma. (Record no. 24604914)

MARC details
000 -LEADER
fixed length control field 02269 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517014825.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201505s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-0851
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00262-015-1656-x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Klein, Oliver
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150521
245 00 - TITLE STATEMENT
Title Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer immunology, immunotherapy : CII
Date of publication, distribution, etc. Apr 2015
300 ## - PHYSICAL DESCRIPTION
Extent 507-18 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, Neoplasm
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Alkylating
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CD4-Positive T-Lymphocytes
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Vaccines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cholesterol
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Combinations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphatic Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Membrane Proteins
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phospholipids
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Saponins
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element T-Lymphocytes, Regulatory
General subdivision immunology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, Ian D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McArthur, Grant A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Li
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Haydon, Andrew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parente, Phillip
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dimopoulos, Nektaria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jackson, Heather
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xiao, Kun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maraskovsky, Eugene
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hopkins, Wendie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stan, Rodica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Weisan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cebon, Jonathan
773 0# - HOST ITEM ENTRY
Title Cancer immunology, immunotherapy : CII
Related parts vol. 64
-- no. 4
-- p. 507-18
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00262-015-1656-x">https://doi.org/10.1007/s00262-015-1656-x</a>
Public note Available from publisher's website

No items available.